title: Biphasic activity of chloroquine in human colorectal cancer cells.
abstract: Autophagy is a homeostatic degradation process that is involved in tumor development and normal development. Autophagy is induced in cancer cells in response to chemotherapeutic agents, and inhibition of autophagy results in enhanced cancer cell death or survival. Chloroquine (CQ), an anti-malarial devrepug, is a lysosomotropic agent and is currently used as a potential anticancer agent as well as an autophagy inhibitor. Here, we evaluate the characteristics of these dual activities of CQ using human colorectal cancer cell line HCT15. The results show that CQ inhibited cell viability in dose-and time-dependent manner in the range between 20 to 80 uM, while CQ did not show any antiproliferative activity at 5 and 10 uM. Cotreatment of CQ with antitumor agent NVP-BEZ235, a dual inhibitor of PI3K/mTOR, rescued the cell viability at low concentrations meaning that CQ acted as an autophagy inhibitor, but CQ induced the lethal effect at high concentrations. Acridine orange staining revealed that CQ at high doses induced lysosomal membrane permeabilization (LMP). High doses of CQ produced cellular reactive oxygen species (ROS) and cotreatment of antioxidants, such as NAC and trolox, with high doses of CQ rescued the cell viability. These results suggest that CQ may exert its dual activities, as autophagy inhibitor or LMP inducer, in concentration-dependent manner.
authors.affiliation: Dept. of Histology, Jeju National University School of Medicine, Jeju 690-756, Korea.
authors.forename: Deokbae
authors.initials: D
authors.lastname: Park
authors.affiliation: Dept. of Histology, Jeju National University School of Medicine, Jeju 690-756, Korea.
authors.forename: Youngki
authors.initials: Y
authors.lastname: Lee
keywords: Autophagy; Chloroquine; HCT15 colorectal cancer cell line; Lysosomal membrane permeabilization (LMP); NVP-BEZ235